Author: FluoGuide A/S

Posted Date:

March 18, 2026

FluoGuide Receives FDA Fast Track Designation for FG001 in High-Grade Glioma

FluoGuide A/S

March 18, 2026
Notice of Annual General Meeting in FluoGuide A/S

FluoGuide A/S

March 10, 2026
FluoGuide A/S Publishes Annual Report For The Fiscal Year 2025

FluoGuide A/S

February 25, 2026
FluoGuide A/S Publishes Interim Report For Q4 2025

FluoGuide A/S

February 25, 2026
FDA Clears FluoGuide’s IND for FG001 in High-Grade Glioma; U.S. Clinical Trial Remains on Track

FluoGuide A/S

February 20, 2026
Invitation to FluoGuide A/S (Nasdaq:FLUO) Live Webcast on 25 February 2026

FluoGuide A/S

February 19, 2026
FluoGuide Submits an IND for FG001, to Initiate First U.S. Registration Trial

FluoGuide A/S

January 27, 2026